{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:48:25Z","timestamp":1791215305940,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T00:00:00Z","timestamp":1081987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Hodgkin's disease (HD) is the most common non\u2010acquired immunodeficiency syndrome (AIDS)\u2010defining malignancy in human immunodeficiency virus (HIV)\u2010infected patients. We analysed the outcome of patients with HIV\u2010associated HD (HIV\u2010HD) with respect to the use and efficacy of highly active antiretroviral therapy (HAART) and other prognostic factors. To evaluate the effects of several variables on overall survival (OS), Kaplan\u2013Meier statistics and extended Cox regression analysis were performed. Response to HAART was used as a time\u2010dependent variable and was defined as an increase of &gt;0\u00b71\u2003\u00d7\u200310<jats:sup>9<\/jats:sup> CD4 cells\/l and\/or at least one viral load &lt;500\u2003copies\/ml during the first 2\u2003years following diagnosis of HIV\u2010HD. Fifty\u2010seven patients with HIV\u2010HD diagnosed between 1990 and 2002 were included in the study. In the Cox model, the only factors independently associated with OS were HAART response [relative hazard (RH) 0\u00b719; 95% confidence interval (CI) 0\u00b706\u20130\u00b760], complete remission (RH 0\u00b730, 95% CI 0\u00b713\u20130\u00b772), and age 45\u2003years (RH 0\u00b723; 95% CI 0\u00b709\u20130\u00b760). Median survival time in patients without HAART response was 18\u00b76\u2003months, whereas the median survival time in patients with HAART response was not reached (89% OS at 24\u2003months). In this cohort, a significant improvement in survival was found in patients with HIV\u2010HD who responded to HAART.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.04934.x","type":"journal-article","created":{"date-parts":[[2004,4,29]],"date-time":"2004-04-29T12:32:50Z","timestamp":1083241970000},"page":"455-462","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus\u2010associated Hodgkin's disease"],"prefix":"10.1111","volume":"125","author":[{"given":"Christian","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Uwe","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Faetkenheuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans\u2010Juergen","family":"Stellbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van Lunzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Stoehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Plettenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan\u2010Christian","family":"Wasmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Mosthaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz\u2010August","family":"Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans\u2010Reinhard","family":"Brodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,4,15]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30446-5"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058617"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200108170-00005"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199612000-00012"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199714000-00010"},{"key":"e_1_2_12_7_1","first-page":"2319","article-title":"Human immunodeficiency virus\u2010associated Hodgkin's disease derives from post\u2010germinal center B cells","volume":"93","author":"Carbone A.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_12_8_1","first-page":"6219","article-title":"Epstein\u2013Barr virus\u2010specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T\u2010cell\u2010based therapy","volume":"61","author":"Chapman A.L.","year":"2001","journal-title":"Cancer Research"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00105-8"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008338915945"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19991112)83:4<481::AID-IJC8>3.0.CO;2-5"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.13.1736"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200301030-00011"},{"key":"e_1_2_12_14_1","first-page":"390","article-title":"The epidemiology of acquired immunodeficiency syndrome malignancies","volume":"27","author":"Goedert J.J.","year":"2000","journal-title":"Seminars in Oncology"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199811193392104"},{"key":"e_1_2_12_16_1","first-page":"1073","article-title":"High prevalence of Epstein\u2013Barr virus in the Reed\u2013Sternberg cells of HIV\u2010associated Hodgkin's disease","volume":"4","author":"Herndier B.G.","year":"1993","journal-title":"American Journal of Pathology"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200111090-00007"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200307040-00013"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.22.1823"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200204)32:4<1080::AID-IMMU1080>3.0.CO;2-R"},{"key":"e_1_2_12_21_1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00126334-200008150-00009","article-title":"Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte\u2010colony\u2010stimulating factor in HIV\u2010infected patients with newly diagnosed Hodgkin's disease: a prospective, multi\u2010institutional AIDS clinical trials group study (ACTG 149)","volume":"24","author":"Levine A.M.","year":"2000","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3589"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02504-6"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10080"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199707010-00009"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770100294"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011201)92:11<2739::AID-CNCR10121>3.0.CO;2-E"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910315)67:6<1614::AID-CNCR2820670624>3.0.CO;2-#"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200209270-00020"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19940501)73:9<2400::AID-CNCR2820730925>3.0.CO;2-C"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900515)65:10<2248::AID-CNCR2820651015>3.0.CO;2-W"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008317426152"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00329-4"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0989"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200205030-00005"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000055305"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.7.1758"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109060344"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.1.146"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.04934.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.04934.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.04934.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:03:38Z","timestamp":1697393018000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.04934.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,15]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.1365-2141.2004.04934.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.04934.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,15]]},"assertion":[{"value":"2004-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}